News | October 09, 2022
BioMarin simplifies organizational structure to increase efficiency
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.
Transformation to pure-play Innovative Medicines company nears completion
_256_384.jpg){kind=logo}
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
He holds a Bachelor’s Degree in Science and has joined the company in 2012 and has over 10 years of experience in pharmaceutical industry
Proceeds from the proposed issue will be utilized to part finance Balaxi’s planned EU GMP-compliant manufacturing facility for Oral Solid Dosages and Liquid Injectables at TSIIC Pharma Formulations SEZ
Hello Patients provides healthcare billing and patients’ management solution
The existing hospital premises has the scope to further scale up the bed capacity as and when required in the future with minimal Capex.
Subscribe To Our Newsletter & Stay Updated
